BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paugh BS, Paugh SW, Bryan L, Kapitonov D, Wilczynska KM, Gopalan SM, Rokita H, Milstien S, Spiegel S, Kordula T. EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 2008;22:455-465. [PMID: 17855624 DOI: 10.1096/fj.07-8276com] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Estrada-Bernal A, Lawler SE, Nowicki MO, Ray Chaudhury A, Van Brocklyn JR. The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells. J Neurooncol 2011;102:353-66. [PMID: 20938717 DOI: 10.1007/s11060-010-0345-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
2 Mahajan-Thakur S, Bien-Möller S, Marx S, Schroeder H, Rauch BH. Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review. Int J Mol Sci 2017;18:E2448. [PMID: 29149079 DOI: 10.3390/ijms18112448] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
3 Kanno Y. The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis. Int J Mol Sci 2019;20:E619. [PMID: 30709025 DOI: 10.3390/ijms20030619] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
4 Schneider G. S1P Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2020;1223:129-53. [PMID: 32030688 DOI: 10.1007/978-3-030-35582-1_7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Gandy KA, Obeid LM. Regulation of the sphingosine kinase/sphingosine 1-phosphate pathway. Handb Exp Pharmacol 2013;:275-303. [PMID: 23563662 DOI: 10.1007/978-3-7091-1511-4_14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
6 Huang WC, Nagahashi M, Terracina KP, Takabe K. Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis. Biomolecules. 2013;3. [PMID: 24286034 DOI: 10.3390/biom3030408] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
7 Honjo K, Munakata S, Tashiro Y, Salama Y, Shimazu H, Eiamboonsert S, Dhahri D, Ichimura A, Dan T, Miyata T, Takeda K, Sakamoto K, Hattori K, Heissig B. Plasminogen activator inhibitor‐1 regulates macrophage‐dependent postoperative adhesion by enhancing EGF‐HER1 signaling in mice. FASEB j 2017;31:2625-37. [DOI: 10.1096/fj.201600871rr] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 7.8] [Reference Citation Analysis]
8 Honda T, Motoyoshi K, Kasahara J, Yamagata K, Takahashi H, Nakamura H, Murayama T. Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: Its role in survival of HeLa cells against ceramide. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158817. [PMID: 32980536 DOI: 10.1016/j.bbalip.2020.158817] [Reference Citation Analysis]
9 de Groot J, Milano V. Improving the prognosis for patients with glioblastoma: the rationale for targeting Src. J Neurooncol 2009;95:151-63. [PMID: 19436954 DOI: 10.1007/s11060-009-9916-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
10 Bryan L, Paugh BS, Kapitonov D, Wilczynska KM, Alvarez SM, Singh SK, Milstien S, Spiegel S, Kordula T. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. Mol Cancer Res 2008;6:1469-77. [PMID: 18819934 DOI: 10.1158/1541-7786.MCR-08-0082] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
11 Canals D, Hannun YA. Novel chemotherapeutic drugs in sphingolipid cancer research. Handb Exp Pharmacol 2013;:211-38. [PMID: 23579458 DOI: 10.1007/978-3-7091-1368-4_12] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
12 Singh R, Lei P, Andreadis ST. PKC-delta binds to E-cadherin and mediates EGF-induced cell scattering. Exp Cell Res 2009;315:2899-913. [PMID: 19591825 DOI: 10.1016/j.yexcr.2009.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
13 Pyne NJ, Pyne S. Sphingosine 1-phosphate and cancer. Nat Rev Cancer. 2010;10:489-503. [PMID: 20555359 DOI: 10.1038/nrc2875] [Cited by in Crossref: 585] [Cited by in F6Publishing: 571] [Article Influence: 53.2] [Reference Citation Analysis]
14 Huang WC, Chen CL, Lin YS, Lin CF. Apoptotic sphingolipid ceramide in cancer therapy. J Lipids 2011;2011:565316. [PMID: 21490804 DOI: 10.1155/2011/565316] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
15 Lv S, Dai C, Liu Y, Sun B, Shi R, Han M, Bian R, Wang R. Cell surface protein C23 affects EGF-EGFR induced activation of ERK and PI3K-AKT pathways. J Mol Neurosci 2015;55:519-24. [PMID: 25015231 DOI: 10.1007/s12031-014-0375-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
16 Morris-hanon O, Marazita MC, Romorini L, Isaja L, Fernandez-espinosa DD, Sevlever GE, Scassa ME, Videla-richardson GA. Palbociclib Effectively Halts Proliferation but Fails to Induce Senescence in Patient-Derived Glioma Stem Cells. Mol Neurobiol 2019;56:7810-21. [DOI: 10.1007/s12035-019-1633-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wie SM, Adwan TS, DeGregori J, Anderson SM, Reyland ME. Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage. J Biol Chem 2014;289:10900-8. [PMID: 24569990 DOI: 10.1074/jbc.M114.551366] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
18 Yin X, Li B, Chen H, Catt KJ. Differential signaling pathways in angiotensin II- and epidermal growth factor-stimulated hepatic C9 cells. Mol Pharmacol 2008;74:1223-33. [PMID: 18687808 DOI: 10.1124/mol.108.048504] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
19 Spiegel S, Milstien S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol. 2011;11:403-415. [PMID: 21546914 DOI: 10.1038/nri2974] [Cited by in Crossref: 496] [Cited by in F6Publishing: 482] [Article Influence: 49.6] [Reference Citation Analysis]
20 Doktorova H, Hrabeta J, Khalil MA, Eckschlager T. Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;159:166-77. [PMID: 26001024 DOI: 10.5507/bp.2015.025] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
21 Xie Z, Liu H, Geng M. Targeting sphingosine-1-phosphate signaling for cancer therapy. Sci China Life Sci 2017;60:585-600. [DOI: 10.1007/s11427-017-9046-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
22 Keller S, Schmidt MHH. EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment. Int J Mol Sci 2017;18:E1295. [PMID: 28629170 DOI: 10.3390/ijms18061295] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 13.0] [Reference Citation Analysis]
23 Song X, Thalacker FW, Nilsen-Hamilton M. Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type β and epidermal growth factor. J Biol Chem 2012;287:12520-8. [PMID: 22334677 DOI: 10.1074/jbc.M111.338079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Sangar V, Funk CC, Kusebauch U, Campbell DS, Moritz RL, Price ND. Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells. Mol Cell Proteomics 2014;13:2618-31. [PMID: 24997998 DOI: 10.1074/mcp.M114.040428] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
25 Kang J. Protein Kinase C (PKC) Isozymes and Cancer. New Journal of Science 2014;2014:1-36. [DOI: 10.1155/2014/231418] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
26 Kegelman TP, Das SK, Hu B, Bacolod MD, Fuller CE, Menezes ME, Emdad L, Dasgupta S, Baldwin AS, Bruce JN, Dent P, Pellecchia M, Sarkar D, Fisher PB. MDA-9/syntenin is a key regulator of glioma pathogenesis. Neuro Oncol 2014;16:50-61. [PMID: 24305713 DOI: 10.1093/neuonc/not157] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
27 Yester JW, Tizazu E, Harikumar KB, Kordula T. Extracellular and intracellular sphingosine-1-phosphate in cancer. Cancer Metastasis Rev 2011;30:577-97. [PMID: 22002715 DOI: 10.1007/s10555-011-9305-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
28 Li SJ, Wei XH, Zhan XM, He JY, Zeng YQ, Tian XM, Yuan ST, Sun L. Adipocyte-Derived Leptin Promotes PAI-1 -Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner. Cancers (Basel) 2020;12:E3864. [PMID: 33371368 DOI: 10.3390/cancers12123864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Young N, Pearl DK, Van Brocklyn JR. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol Cancer Res 2009;7:23-32. [PMID: 19147534 DOI: 10.1158/1541-7786.MCR-08-0061] [Cited by in Crossref: 77] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
30 Park HJ, Chi GY, Choi YH, Park SH. Lupeol suppresses plasminogen activator inhibitor-1-mediated macrophage recruitment and attenuates M2 macrophage polarization. Biochem Biophys Res Commun 2020;527:889-95. [PMID: 32430175 DOI: 10.1016/j.bbrc.2020.04.160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Park D, Kim Y, Kim H, Kim K, Lee YS, Choe J, Hahn JH, Lee H, Jeon J, Choi C, Kim YM, Jeoung D. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ. Mol Cells 2012;33:563-74. [PMID: 22610405 DOI: 10.1007/s10059-012-2294-1] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 9.4] [Reference Citation Analysis]
32 Pulkoski-Gross MJ, Jenkins ML, Truman JP, Salama MF, Clarke CJ, Burke JE, Hannun YA, Obeid LM. An intrinsic lipid-binding interface controls sphingosine kinase 1 function. J Lipid Res 2018;59:462-74. [PMID: 29326159 DOI: 10.1194/jlr.M081307] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
33 Belda-Iniesta C, de Castro Carpeño J, Sereno M, González-Barón M, Perona R. Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach. Clin Transl Oncol 2008;10:73-7. [PMID: 18258505 DOI: 10.1007/s12094-008-0159-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
34 Yao C, Wu S, Li D, Ding H, Wang Z, Yang Y, Yan S, Gu Z. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro. Mol Oncol 2012;6:392-404. [PMID: 22583777 DOI: 10.1016/j.molonc.2012.04.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
35 Cho H, Kang J, Kim T, Park K, Kim C, Lee I, Min K, Magae J, Nakajima H, Bae Y, Chang Y. Suppression of PAI-1 expression through inhibition of the EGFR-mediated signaling cascade in rat kidney fibroblast by ascofuranone. J Cell Biochem 2009;107:335-44. [DOI: 10.1002/jcb.22130] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
36 Sukocheva OA. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming. Int J Mol Sci. 2018;19:pii: E420. [PMID: 29385066 DOI: 10.3390/ijms19020420] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
37 Teodorczyk M, Martin-Villalba A. Sensing invasion: cell surface receptors driving spreading of glioblastoma. J Cell Physiol. 2010;222:1-10. [PMID: 19688773 DOI: 10.1002/jcp.21901] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
38 Piao XY, Li W, Li Z, Zhang N, Fang H, Zahid D, Qu Q. Forced FoxO1:S249V expression suppressed glioma cell proliferation through G2/M cell cycle arrests and increased apoptosis. Neurol Res 2019;41:189-98. [PMID: 30453847 DOI: 10.1080/01616412.2018.1548724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Alvarez SE, Harikumar KB, Hait NC, Allegood J, Strub GM, Kim EY, Maceyka M, Jiang H, Luo C, Kordula T. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 2010;465:1084-1088. [PMID: 20577214 DOI: 10.1038/nature09128] [Cited by in Crossref: 518] [Cited by in F6Publishing: 513] [Article Influence: 47.1] [Reference Citation Analysis]
40 Zhao CG, Qin J, He XJ, Guan YC, Jia Y, Lei W. Sphingosine-1-phosphate is a possible fibrogenic factor in gluteal muscle fibrosis. Physiol Res 2013;62:691-9. [PMID: 23869887 DOI: 10.33549/physiolres.932441] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
41 Symonds JM, Ohm AM, Carter CJ, Heasley LE, Boyle TA, Franklin WA, Reyland ME. Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors. Cancer Res 2011;71:2087-97. [PMID: 21335545 DOI: 10.1158/0008-5472.CAN-10-1511] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
42 Benkheil M, Paeshuyse J, Neyts J, Van Haele M, Roskams T, Liekens S. HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis. Biochem Pharmacol. 2018;155:305-315. [PMID: 30012461 DOI: 10.1016/j.bcp.2018.07.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
43 Bryan L, Kordula T, Spiegel S, Milstien S. Regulation and functions of sphingosine kinases in the brain. Biochim Biophys Acta 2008;1781:459-66. [PMID: 18485923 DOI: 10.1016/j.bbalip.2008.04.008] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 5.5] [Reference Citation Analysis]
44 Orr Gandy KA, Adada M, Canals D, Carroll B, Roddy P, Hannun YA, Obeid LM. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation. FASEB J 2013;27:3155-66. [PMID: 23629860 DOI: 10.1096/fj.13-228460] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
45 Reyland ME, Jones DN. Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease. Pharmacol Ther 2016;165:1-13. [PMID: 27179744 DOI: 10.1016/j.pharmthera.2016.05.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
46 Park HJ, Chi GY, Choi YH, Park SH. The root bark of Morus alba L. regulates tumor-associated macrophages by blocking recruitment and M2 polarization of macrophages. Phytother Res 2020;34:3333-44. [PMID: 32677743 DOI: 10.1002/ptr.6783] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
47 Inoue H, Hattori T, Zhou X, Etling EB, Modena BD, Trudeau JB, Holguin F, Wenzel SE. Dysfunctional ErbB2, an EGF receptor family member, hinders repair of airway epithelial cells from asthmatic patients. J Allergy Clin Immunol 2019;143:2075-2085.e10. [PMID: 30639343 DOI: 10.1016/j.jaci.2018.11.046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
48 Wyrzykowska P, Stalińska K, Wawro M, Kochan J, Kasza A. Epidermal growth factor regulates PAI-1 expression via activation of the transcription factor Elk-1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2010;1799:616-21. [DOI: 10.1016/j.bbagrm.2010.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
49 Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S. Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 2008;9:662-73. [PMID: 18691013 DOI: 10.2174/138945008785132402] [Cited by in Crossref: 215] [Cited by in F6Publishing: 207] [Article Influence: 16.5] [Reference Citation Analysis]
50 Ohm AM, Tan AC, Heasley LE, Reyland ME. Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer. Oncogene 2017;36:4370-8. [PMID: 28368426 DOI: 10.1038/onc.2017.27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
51 Rabieian R, Boshtam M, Zareei M, Kouhpayeh S, Masoudifar A, Mirzaei H. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis. J Cell Biochem 2018;119:17-27. [PMID: 28520219 DOI: 10.1002/jcb.26146] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 19.8] [Reference Citation Analysis]
52 Symonds JM, Ohm AM, Tan AC, Reyland ME. PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells. Oncotarget 2016;7:17905-19. [PMID: 26918447 DOI: 10.18632/oncotarget.7560] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
53 Riboni L, Abdel Hadi L, Navone SE, Guarnaccia L, Campanella R, Marfia G. Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks. Cells 2020;9:E337. [PMID: 32024090 DOI: 10.3390/cells9020337] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
54 Alberti C, Pinciroli P, Valeri B, Ferri R, Ditto A, Umezawa K, Sensi M, Canevari S, Tomassetti A. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer. Oncogene 2012;31:4139-49. [DOI: 10.1038/onc.2011.572] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 6.9] [Reference Citation Analysis]
55 Li S, Wei X, He J, Tian X, Yuan S, Sun L. Plasminogen activator inhibitor-1 in cancer research. Biomed Pharmacother. 2018;105:83-94. [PMID: 29852393 DOI: 10.1016/j.biopha.2018.05.119] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 17.3] [Reference Citation Analysis]
56 Aroor AR, Shukla SD. Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression. World J Hepatol 2011; 3(9): 250-255 [PMID: 21969878 DOI: 10.4254/wjh.v3.i9.250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
57 Zhou K, Blom T. Trafficking and Functions of Bioactive Sphingolipids: Lessons from Cells and Model Membranes. Lipid Insights 2015;8:11-20. [PMID: 26715852 DOI: 10.4137/LPI.S31615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
58 Papa E, Weller M, Weiss T, Ventura E, Burghardt I, Szabó E. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma. Cell Death Dis 2017;8:3210. [PMID: 29238047 DOI: 10.1038/s41419-017-0051-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]